跳至主要内容
成分CosIng 更新 15 十月 2010

THIOCTIC ACID

1,2-Dithiolane-3-pentanoic acid, (+/-)-

THIOCTIC ACID 列于欧盟 CosIng 清单,但本页尚未关联任何直接的附件记录。

一览

功能
Antioxidant
CAS
1077-28-7
EC
214-071-2
欧盟附件
未列入未关联欧盟附件记录。这不是批准。

按市场划分的监管证据

此矩阵将已核实的成分规则与已映射但尚未导入的来源区分开。没有已导入的规则并不意味着该成分获准使用。

对比市场

滑动或横向滚动以查看所有列。

市场证据状态记录来源语言
European Union来源已映射
Inventory entry; no linked annex rule
0English and EU languages
Great Britain来源已映射
Official source mapped; ingredient rule not imported
0English
Canada来源已映射
Official source mapped; ingredient rule not imported
0English and French
New Zealand来源已映射
Official source mapped; ingredient rule not imported
0English
ASEAN来源已映射
Official source mapped; ingredient rule not imported
0English and national languages
China来源已映射
Official source mapped; ingredient rule not imported
0Chinese with selected English material
Japan已关联证据
Restricted
打开此证据
1Japanese; official English translation available
South Korea来源已映射
Official source mapped; ingredient rule not imported
0Korean with some English names
United States来源已映射
Official source mapped; ingredient rule not imported
0English
Australia来源已映射
Official source mapped; ingredient rule not imported
0English
Brazil来源已映射
Official source mapped; ingredient rule not imported
0Portuguese with INCI crosswalks
India来源已映射
Official source mapped; ingredient rule not imported
0English and Hindi
Saudi Arabia来源已映射
Official source mapped; ingredient rule not imported
0Arabic and English

THIOCTIC ACID 的清单详情

INCI 名称

THIOCTIC ACID

INN 名称

Thioctic acid [JAN]

说明

1,2-Dithiolane-3-pentanoic acid, (+/-)-

记录出处

清单参考
60299
已导入的身份
THIOCTIC ACID
来源更新
15/10/2010
欧盟委员会 CosIng 来源备注

关键数据

限制
—
功能
  • ANTIOXIDANT

    Inhibiting reactions promoted by oxygen, thus avoiding oxidation and rancidity.

化学身份与性质

CAS 1077-28-7 的 PubChem 二维化学结构
CAS 1077-28-7PubChem CID 864

alpha Lipoic acid

Lipoic acid is a heterocyclic thia fatty acid comprising pentanoic acid with a 1,2-dithiolan-3-yl group at the 5-position. It has a role as a geroprotector and a fundamental metabolite. It is a member of dithiolanes, a heterocyclic fatty acid and a thia fatty acid. It is functionally related to an octanoic acid. It is a conjugate acid of a lipoate. — ChEBI

IUPAC 名称
5-(dithiolan-3-yl)pentanoic acid
分子式
C8H14O2S2
分子量
206.3 g/mol
精确质量
206.04352203 Da
XLogP3
1.7
拓扑极性表面积
87.9 Ų
氢键供体
1
氢键受体
4
共价单元
1
已定义的立体中心
0

又称

thioctic acidalpha-Lipoic acid6,8-Thioctic acidBiletanDL-6,8-Thioctic acidThioctsanthioctateThiocacid
另有 16 个已报告名称
ThioctanTioctic AcidAcidum thiocticumA-lipoicum acidumLipoic acid, dl-Lipoic acid, alphabiomoliponAlphaLipogammabiomo liponespa liponAlpha LipogammaPleomix AlphaVerla LiponAlphaLipon StadaAlpha Lippon ALAlpha Lipon Stada
外部数据库标识符

来自其他科学数据库的证据

NIH PubChem PUG-View
标识符精确匹配864

Attributed physical-property, hazard, environmental and use annotations.

  • Note: This chemical does not meet GHS hazard criteria for 6.5% (28 of 430) of reports. 来源: European Chemicals Agency (ECHA)
  • Signal: Warning 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (93.5%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (48.6%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (46.5%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (47%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H411 (46.5%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P261, P264, P264+P265, P270, P272, P273, P280, P301+P317, P302+P352, P305+P351+P338, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P391, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 430 reports by companies from 16 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 28 of 430 reports by companies.; There are 14 notifications provided by 402 of 430 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Note: This chemical does not meet GHS hazard criteria for 42.3% (52 of 123) of reports. 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (57.7%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (31.7%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (31.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (31.7%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H412 (19.5%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 123 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 52 of 123 reports by companies.; There are 7 notifications provided by 71 of 123 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Health Effects: Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, incre 来源: Toxin and Toxin Target Database (T3DB)
  • Toxicity Summary: ALA is generally considered a safe drug. A daily dose of 200 mg/day to 2400 mg/day of ALA is deemed safe without significant adverse effects. However, there is no reported safe dose in children.; A notable case in literature demonstrated status epilepticus (SE) that subsided within a few days. The seizures were treated per normal standards for SE.; In the last 2 decades, there have been few reported cases of ALA toxicity in humans. Most of these cases occur in children and are treatable. Though there is no established lethal dosage of ALA for humans, studies have shown that a high dose of 121 mg/kg body weight/day was associated with alterations in liver enzymes and liver function. Therefore, there are potentially harmful adverse effects from overdosing on ALA, and more studies are necessary to determine the toxicity. 来源: StatPearls
  • Toxicity Summary: (R)-lipoic acid is a cholinesterase or acetylcholinesterase (AChE) inhibitor. A cholinesterase inhibitor (or 'anticholinesterase') suppresses the action of acetylcholinesterase. Because of its essential function, chemicals that interfere with the action of acetylcholinesterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses, followed by muscle spasms and ultimately death. Nerve gases and many substances used in insecticides have been shown to act by binding a serine in the active site of acetylcholine esterase, inhibiting the enzyme completely. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop. Among the most common acetylcholinesterase inhibitors are phosphorus-based compounds, which are designed to bind to the active site of the enzyme. The structural requirements are a phosphorus atom bearing two lipophilic groups, a leaving group (such as 来源: Toxin and Toxin Target Database (T3DB)
  • Uses: Nutrition, biochemical research /Thioctic acid, dl-form/ 来源: Hazardous Substances Data Bank (HSDB)
  • Uses: THERAPEUTIC CATEGORY: Treatment of liver disease; antidote to poisonous mushrooms (Amanita species). 来源: Hazardous Substances Data Bank (HSDB)
  • Uses: Use (kg; approx.) in Germany (2009): >7500; Consumption (g per capita; approx.) in Germany (2009): 0.0916; Calculated removal (%): 96.4 来源: NORMAN Suspect List Exchange
  • Uses: For nutritional supplementation, also for treating dietary shortage or imbalance. 来源: Toxin and Toxin Target Database (T3DB)

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

欧盟官方成分名称证据

该成分名称与 2025 年欧盟官方通用成分名称词汇表完全匹配。

配方功能重叠的成分

其他官方和科学来源

11 个可用于核查此身份的外部数据库

THIOCTIC ACID 在 CosIng 清单中的呈现方式

CosIng 清单将 THIOCTIC ACID 列为化妆品成分,本页将其关联到 0 条附件记录。清单条目记录名称和标识符,而附件记录显示该物质在欧盟化妆品法规中被禁用、限用或列入准用清单的情况。

在官方数据中,THIOCTIC ACID 还被标记了 1 项化妆品功能。功能标识描述预期用途,但不能取代在配方或标签工作之前对关联附件记录的监管审查。

常见问题

THIOCTIC ACID 列于欧盟 CosIng 成分清单,目前没有关联直接的附件限制记录。没有附件链接并不保证可无限制使用——配方前请务必对照现行官方 CosIng 数据库核实。

根据欧盟 CosIng 清单,THIOCTIC ACID 带有以下功能标识:

CAS 1077-28-7 可能出现在多条欧盟附件记录中。查看 CAS 查询页面可显示共用该标识符的所有附件 II–VI 条目,有助于识别同一化学物质在不同附件中的监管状态。

使用 INCI 检查器在选定市场中筛查完整成分表,或在所有受支持的市场数据集中对比该物质。

THIOCTIC ACID 的来源说明

本页转载欧盟委员会公开化妆品成分资料中 THIOCTIC ACID 的 CosIng 清单条目,即使目前没有附加直接的附件匹配,也会显示关联的标识符。

请使用本清单页面研究 THIOCTIC ACID 并对比关联记录,但在作出监管决定之前,请对照现行官方来源文本和法律核实限制和法律地位。

工具与后续步骤

检查您的配方

扫描完整的 INCI 成分表,检出 THIOCTIC ACID 及任何关联的欧盟附件限制或致敏原标记。

INCI 检查器

搜索相似成分

查找与 THIOCTIC ACID、其标识符或相近名称变体相关的其他清单成分和附件条目。

搜索